Anthropic sues US government over security designation
Anthropic has filed two federal lawsuits against the US government, challenging the Pentagon's designation of the company as a 'supply chain risk to national security,' a label typically reserved for foreign adversaries. The San Francisco-based AI firm argues that this designation is unconstitutional retaliation for its opposition to the use of its technology for mass surveillance and autonomous weapons. Microsoft has expressed its support for Anthropic in this legal battle, which could potentially cost the company billions in revenue.
Thinking Machines Lab partners with Nvidia for AI advancement
Mira Murati's Thinking Machines Lab has entered a multiyear partnership with Nvidia, which includes a significant investment and a commitment to deploy at least one gigawatt of Nvidia's Vera Rubin systems for AI model training. The collaboration aims to enhance the customization and capability of AI systems, with Nvidia's CEO Jensen Huang highlighting the startup's potential to advance the frontier of AI. Although the exact size of Nvidia's investment was not disclosed, the partnership signals a strategic move for Thinking Machines, which has grown from 30 to approximately 120 employees since its founding last year.
China restricts OpenClaw AI use in state enterprises
Chinese authorities have implemented restrictions on the use of OpenClaw AI technology within state-run enterprises and government agencies, including major banks, to mitigate potential security risks. Recent notices have warned these entities against installing OpenClaw software on office devices, with instructions to report any existing installations for security checks and possible removal.
OpenAI CEO announces major investment in data centers
OpenAI's CEO Sam Altman announced plans for a substantial investment in data centers equipped with advanced chips to support the company's AI development initiatives. This effort follows SoftBank's completion of a $30 billion investment in OpenAI, which included a total transaction value of $41 billion and secured an 11% stake for the firm. The funding, finalized through SoftBank's Vision Fund 2, will assist OpenAI in covering the costs associated with training next-generation AI models and advancing its competitive position against rivals.
BioNTech Founders Resign to Launch AI mRNA Company
Ugur Sahin and Özlem Türeci, co-founders of BioNTech, announced their resignation as CEOs to establish a new independent company focused on developing AI-powered mRNA therapies. The duo, who hold approximately 15% of BioNTech, aim to leverage their expertise to create next-generation treatments beyond oncology, although specific details remain undisclosed. BioNTech will continue to concentrate on its late-stage pipeline, including mRNA candidates and antibody-drug conjugates.
